Can Europe’s Beating Cancer Plan Make it an Innovation Leader?
EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the continent’s push to catch up with the US and China on biopharmaceutical innovation. Read more on PharmaBoardroom.
Health Innovation: No one left behind
We call on the Commission to create a High-Level Forum on Better Access to Health Innovation as proposed by the European Health Coalition, to develop concrete solutions for the introduction of new technologies into health systems in a way that is sustainable, widely available and accessible to European citizens.
European Health Management Association (EHMA) is pleased to launch the Call for Abstracts for the EHMA 2021 Annual Conference....
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.